Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,352,718
-$23,117 QoQ
Shares Held
56,176
+14.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,145
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Integrated Advisors Network LLC holds $55,348,452 across 12 Drug Manufacturers - General names. PFE ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,637 | $17,556,058 | |
| 2 | ABBV |
AbbVie Inc.
|
46,747 | $11,763,415 | |
| 3 | JNJ |
Johnson & Johnson
|
32,020 | $8,132,119 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,726 | $7,032,291 | |
| 5 | AMGN |
Amgen Inc
|
18,675 | $6,762,591 | |
| 6 | PFE |
Pfizer Inc
This page
|
56,176 | $1,352,718 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,597 | $1,013,939 | |
| 8 | NVS |
Novartis AG
|
2,809 | $440,226 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,352,718 | 56,176 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,375,835 | 48,997 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,376,721 | 55,290 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,457,991 | 57,221 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,541,179 | 63,580 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,769,593 | 69,834 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,532,638 | 57,770 | Shares | Sole | 2025-02-25 | |
| 2024-09-30 | $1,852,565 | 64,014 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,513,410 | 54,089 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,659,977 | 59,819 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,397,409 | 48,538 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $1,687,026 | 50,860 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $2,119,260 | 57,777 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,207,157 | 54,097 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,067,072 | 59,857 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,750,184 | 62,847 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,476,633 | 66,310 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,452,593 | 66,691 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,765,618 | 63,770 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,858,530 | 66,462 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,383,669 | 60,870 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,156,808 | 59,531 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,325,766 | 63,183 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,104,999 | 57,357 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,706,221 | 52,178 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,655,857 | 50,731 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||